ArticleTherapeutic advances in medical oncology2018

Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management.

John Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.